- Lobbying
- Lobbying by Optimer Pharmaceuticals, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Dayle Lewis Cristinzio | Sen Harry Reid, Leg Dir; Rep Steny Hoyer, Sr Leg Asst Sen Harry Reid, Leg Dir, Rep. Steny Hoyer Sr Leg |
- - | Sen Charles Schumer, Dir Econ Dev & Approp |
-- - | Asst; Sen Charles Schumer, Dir Econ Dev&Approo |
-- -- | Asst; Sen Charles Schumer, Dir Econ Dev & Appro |
Kevin Brennan | n/a |
Dayle Lewis Crintinzio | n/a |
Nick Littlefield | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare drug reimbursement..
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare drug reimbursement..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate